Advertisement
Canada markets open in 6 hours 34 minutes

  • S&P/TSX

    22,259.16
    -31.46 (-0.14%)
     

  • S&P 500

    5,187.67
    -0.03 (-0.00%)
     

  • DOW

    39,056.39
    +172.13 (+0.44%)
     

  • CAD/USD

    0.7282
    -0.0006 (-0.09%)
     

  • CRUDE OIL

    79.37
    +0.38 (+0.48%)
     

  • Bitcoin CAD

    84,566.60
    -1,249.97 (-1.46%)
     

  • CMC Crypto 200

    1,313.72
    +13.62 (+1.05%)
     

  • GOLD FUTURES

    2,320.90
    -1.40 (-0.06%)
     

  • RUSSELL 2000

    2,055.14
    -9.51 (-0.46%)
     

  • 10-Yr Bond

    4.4920
    +0.0290 (+0.65%)
     

  • NASDAQ futures

    18,146.00
    -40.50 (-0.22%)
     

  • VOLATILITY

    13.00
    -0.23 (-1.74%)
     

  • FTSE

    8,354.05
    +40.38 (+0.49%)
     

  • NIKKEI 225

    38,073.98
    -128.39 (-0.34%)
     

  • CAD/EUR

    0.6777
    +0.0001 (+0.01%)
     

Stocks in play: Cronos Group Inc.

Baystreet.ca

Announced that it has entered into a multi-year supply agreement with MediPharm Labs Corp., whereby MediPharm Labs will supply Cronos Group with approximately $30 million of high-quality private label cannabis concentrate over 18 months, and, subject to certain renewal and purchase options, potentially up to $60 million over 24 months. In addition, Cronos Group has selected MediPharm Labs’ state of the art extraction facility in Barrie, Ontario, as a preferred partner to fulfill certain of its processing needs, under a separate tolling arrangement. Cronos Group Inc. shares T.CRON are trading up $1.13 at $20.47.